The Disease Modifying Drugs (DMDs) has radically improved the success of Multiple Sclerosis (MS) treatment by preventing relapses and delaying disease progression.
No takes yet. Share an insight, caveat, or question.
Çakan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: